SkyePharma has entered into an agreement with Dr Reddy's Laboratories to undertake a feasibility study. The costs of this study, of a product utilizing two of SkyePharma's proprietary drug delivery systems, will be paid for by Dr Reddy's.
Subscribe to our email newsletter
SkyePharma will also receive a small upfront payment. If the feasibility study is successful, full development activities will begin later in 2008.
Frank Condella, CEO of SkyePharma, said: “We are very pleased to enter into this collaboration with Dr Reddy’s on a new product development opportunity and hope to extend the collaboration to other products.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.